SCHEMBL925778

SCHEMBL925778

Cc1nc(NC(=O)c2ccco2)sc1-c1ccc(Cl)nc1NS(=O)(=O)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 3/20 0.51
TDP1 Q9NUW8 1/20 0.51
MEN1 O00255 8/20 0.49
KMT2A Q03164 8/20 0.49
MAPT P10636 7/20 0.49
ALDH1A1 P00352 8/20 0.47
HPGD P15428 5/20 0.47
PIK3CD O00329 4/20 0.47
PIK3CA P42336 4/20 0.47
PIK3CB P42338 4/20 0.47
PIK3CG P48736 4/20 0.47
POLB P06746 3/20 0.47
SMN1; SMN2 Q16637 5/20 0.47
RAB9A P51151 3/20 0.47
NPC1 O15118 2/20 0.47
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
KDM4E B2RXH2 3/20 0.46
LMNA P02545 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL926624 0.85 PIK3CD (0.60) MEN1KMT2AMAPTALDH1A1PIK3CD
SCHEMBL927226 0.83 PIK3CD (0.50) MEN1KMT2AMAPTALDH1A1PIK3CD
SCHEMBL927079 0.81 CSNK1D (0.51) MEN1KMT2AMAPTALDH1A1PIK3CD
SCHEMBL924648 0.80 PIK3CD (0.51) MEN1KMT2AMAPTALDH1A1PIK3CD
SCHEMBL925776 0.79 PIK3CD (0.76) PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL927291 0.78 PI4KB (0.57) PKMMEN1KMT2AMAPTALDH1A1
SCHEMBL4509798 0.73 PIK3CA (0.48) MEN1KMT2AMAPTALDH1A1PIK3CD
SCHEMBL4517148 0.71 PIK3CA (0.46) MEN1KMT2AMAPTALDH1A1PIK3CD
SCHEMBL4527356 0.69 ALDH1A1 (0.47) TDP1MEN1KMT2AMAPTALDH1A1
SCHEMBL3587905 0.69 PKM (1.00) PKMTDP1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7868188-B2 5-heteroaryl thiazoles and their use as PI3K inhibitors ASTRAZENECA AB (SE) 2011-01-11 US disclosed
EP-1841763-B1 5-HETEROARYL THIAZOLES AND THEIR USE AS PI3K INHIBITORS ASTRAZENECA AB (SE) 2010-06-30 EP disclosed
US-20080132502-A1 5-Heteroaryl Thiazoles And Their Use As PI3K Inhibitors ASTRAZENECA AB (SE) 2008-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132502-A1 5-Heteroaryl Thiazoles And Their Use As PI3K Inhibitors MTOR, PIK3R5, PIK3CA PKM 459/4885TDP1 2766/4885MEN1 1222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.